Coeptis Therapeutics Holdings, Inc. (COEP)

NASDAQ: COEP · Real-Time Price · USD

12.18

-0.08 (-0.65%)

Feb 10, 2026, 4:00 PM EST - Market closed

COEP Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	69	11	27	30	2,494	338
Market Cap Growth	88.60%	-57.71%	-10.53%	-98.80%	637.84%	-
Enterprise Value	64	12	26	26	2,497	-
Last Close Price	12.18	5.50	15.68	30.63	200.00	203.80
PS Ratio	125.39	-	-	-	33258.23	10990.00
PB Ratio	6.06	2.92	32.85	6.71	1061.15	-65.73
P/TBV Ratio	7.56	4.28	32.85	6.71	1061.15	-
EV/Sales Ratio	128.01	-	-	-	33296.44	-
Debt / Equity Ratio	0.03	0.36	1.50	0.46	1.74	-0.41
Asset Turnover	0.04	-	-	-	0.02	0.03
Quick Ratio	2.00	0.12	0.51	1.75	0.79	0.04
Current Ratio	2.21	0.23	0.59	1.81	0.79	0.04
Return on Equity (ROE)	-171.91%	-464.73%	-807.49%	-1104.48%	-	-
Return on Assets (ROA)	-71.41%	-93.24%	-215.14%	-291.15%	-248.47%	-451.53%
Return on Capital Employed (ROCE)	-115.20%	-228.80%	-1358.10%	-595.40%	-351.10%	134.80%
Earnings Yield	-17.91%	-86.79%	-79.54%	-125.73%	-0.54%	-2.71%
FCF Yield	-12.07%	-58.80%	-27.08%	-12.97%	-0.18%	-0.93%
Buyback Yield / Dilution	82.00%	-49.84%	-79.70%	-30.98%	-79.11%	-18.53%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q